Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome
- PMID: 16142760
- DOI: 10.1002/art.21250
Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome
Abstract
Objective: Churg-Strauss syndrome (CSS) is classified among the so-called antineutrophil cytoplasmic antibody-associated systemic vasculitides (AASVs) because of its clinicopathologic features that overlap with the other AASVs. However, while antineutrophil cytoplasmic antibodies (ANCAs) are consistently found in 75-95% of patients with Wegener's granulomatosis or microscopic polyangiitis, their prevalence in CSS varies widely and their clinical significance remains uncertain. We undertook this study to examine the prevalence and antigen specificity of ANCAs in a large cohort of patients with CSS. Moreover, we evaluated the relationship between ANCA positivity and clinicopathologic features.
Methods: Immunofluorescence and enzyme-linked immunosorbent assay were used to determine the presence or absence of ANCAs in 93 consecutive patients at the time of diagnosis. The main clinical and pathologic data, obtained by retrospective analysis, were correlated with ANCA status.
Results: ANCAs were present by immunofluorescence in 35 of 93 patients (37.6%). A perinuclear ANCA (pANCA) pattern was found in 26 of 35 patients (74.3%), with specificity for myeloperoxidase (MPO) in 24 patients, while a cytoplasmic ANCA pattern, with specificity for proteinase 3, was found in 3 of 35 patients (8.6%). Atypical patterns were found in 6 of 30 patients with anti-MPO antibodies (20.0%). ANCA positivity was associated with higher prevalences of renal disease (51.4% versus 12.1%; P < 0.001) and pulmonary hemorrhage (20.0% versus 0.0%; P = 0.001) and, to a lesser extent, with other organ system manifestations (purpura and mononeuritis multiplex), but with lower frequencies of lung disease (34.3% versus 60.3%; P = 0.019) and heart disease (5.7% versus 22.4%; P = 0.042).
Conclusion: ANCAs are present in approximately 40% of patients with CSS. A pANCA pattern with specificity for MPO is found in most ANCA-positive patients. ANCA positivity is mainly associated with glomerular and alveolar capillaritis.
Comment in
-
Churg-Strauss syndrome: just one disease entity?Arthritis Rheum. 2005 Sep;52(9):2589-93. doi: 10.1002/art.21253. Arthritis Rheum. 2005. PMID: 16142739 No abstract available.
Similar articles
-
Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.J Rheumatol. 2001 Jul;28(7):1584-90. J Rheumatol. 2001. PMID: 11469466
-
Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome--62 patients.J Rheumatol. 1993 Aug;20(8):1345-9. J Rheumatol. 1993. PMID: 7901412
-
Churg-Strauss angiitis.Best Pract Res Clin Rheumatol. 2009 Jun;23(3):355-66. doi: 10.1016/j.berh.2009.02.004. Best Pract Res Clin Rheumatol. 2009. PMID: 19508943 Review.
-
Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.Am J Kidney Dis. 2003 Mar;41(3):539-49. doi: 10.1053/ajkd.2003.50142. Am J Kidney Dis. 2003. PMID: 12612976
-
Antineutrophil cytoplasmic antibodies (ANCA).Autoimmunity. 2005 Feb;38(1):93-103. doi: 10.1080/08916930400022673. Autoimmunity. 2005. PMID: 15804710 Review.
Cited by
-
COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis?Rheumatol Int. 2021 Aug;41(8):1515-1521. doi: 10.1007/s00296-021-04896-2. Epub 2021 May 25. Rheumatol Int. 2021. PMID: 34032896 Free PMC article. Review.
-
Clinical presentation of Churg-Strauss syndrome in children: A 12-year-old-boy with ANCA-negative Churg-Strauss syndrome.Respir Med Case Rep. 2012 Nov 7;7:4-7. doi: 10.1016/j.rmcr.2012.09.004. eCollection 2012. Respir Med Case Rep. 2012. PMID: 26029598 Free PMC article.
-
Central nervous system vasculitis: still more questions than answers.Curr Neuropharmacol. 2011 Sep;9(3):437-48. doi: 10.2174/157015911796557920. Curr Neuropharmacol. 2011. PMID: 22379458 Free PMC article.
-
Long-term Safety and Efficacy of Benralizumab for Eosinophilic Granulomatosis with Polyangiitis Complicated with Severe Neuropathy.Intern Med. 2023 May 15;62(10):1553-1556. doi: 10.2169/internalmedicine.0613-22. Epub 2022 Sep 28. Intern Med. 2023. PMID: 36171130 Free PMC article.
-
Pulmonary granulomatosis of genetic origin.Eur Respir Rev. 2021 Apr 29;30(160):200152. doi: 10.1183/16000617.0152-2020. Print 2021 Jun 30. Eur Respir Rev. 2021. PMID: 33927005 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous